List view / Grid view
The small normal Raman cross-section of glucose is a major challenge in its detection by surface enhanced Raman spectroscopy (SERS) for medical applications, such as blood glucose level monitoring of diabetic patients and evaluation of patients with other medical conditions, since glucose is a marker for many human diseases. Here…
The FDA has approved Admelog, a short-acting insulin indicated to improve control in blood sugar levels in diabetes...
Researchers have designed synthetic beta cells that secrete insulin in response to high blood sugar...
Experimental research suggests that statins may impair the production of insulin...
Researchers have collaborated to design a smart bandage that could eventually heal chronic wounds...
Scientists have developed a new gel patch prototype that could speed up the healing of a skin wound while minimising the formation of scars...
Researchers have described a new method to study biochemical changes that occur in the pancreas during the development of diabetes...
Researchers have developed a method that could make magnetic resonance imaging (MRI) multicoloured - a strategy that could serve as a research tool and even aid disease diagnosis...
Oramed announced today the appointment of Dr Simon Bruce MD to the newly created position of Vice President of Medical Affairs...
European Pharmaceutical Review, Issue 2 of 2016 focused on nanotechnology and stem cell technology to monitor glucose and prevent diabetes, respectively. The aim of this review is to sensitise the technology innovators in this field by providing expert opinions on biomedical products and technologies that have come the closest so…
Over the last decade, research has revealed more about the human gut microbiome—the environment within the gastrointestinal tract—where microbes, especially bacteria, reside.
More work needs to be done to examine the real world effects of the commonly prescribed diabetes drug empagliflozin, new research finds...
In the first large pragmatic trial of its kind in the United States, results from a study show that checking finger-stick blood sugars may not help diabetes patients who do not use insulin.
19 April 2017 | By Niamh Marriott, Junior Editor
GeNeuro have started a Phase 2a clinical study in Australia with GNbAC1 in patients with Type 1 diabetes. GNbAC1 is a monoclonal antibody designed to...
The annual Drugs to Watch report forecasts that eight new drugs will enter the market in 2017 and achieve blockbuster sales of more than $900 billion by 2021...
